Khattar Jack A. 4

What Happened

• Jack A. Khattar, a director of Cognition Therapeutics, was granted 25,000 restricted stock units (RSUs) on June 17, 2026. The reported acquisition price is $0.00 per RSU (i.e., no cash paid at grant).
• This is an award/grant (Form 4 transaction code "A"), not an open-market purchase or sale. RSUs convert to shares upon settlement subject to vesting conditions, so this is a compensation/retention award rather than an immediate market purchase.

Key Details

• Transaction date: 2026-06-17; Filing date: 2026-06-22 (Form 4 filed five days after the transaction date, which appears to be later than the typical two-business-day deadline).
• Amount: 25,000 RSUs granted at $0.00 per unit.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: Each RSU is a contingent right to one share on settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) the date of the issuer’s next annual meeting of stockholders, and only if the director remains in continuous service through the applicable vesting date.

Context

• RSU grants are common for directors and are typically part of compensation or retention arrangements; they do not represent an immediate cash investment or sale by the insider.
• Upon vesting and settlement, each RSU would convert into one share of common stock (subject to the conditions above); tax withholding or other settlement mechanics could apply at that time.